TCU HIV/AIDS Risk Assessment
View PDF - TCU HIV_AIDS Risk Assessment.pdf
1. Joe, G. W., Menon, R., Copher, J. I., & Simpson, D. D. (1990, December). Needle-use and sex risk indices: A methodological report. Research in Progress: National AIDS Demonstration Research (NADR) Project. Bethesda, MD: NOVA Research Company. 2. Joe, G. W., Simpson, D. D., Watson, D. D., Williams, M. L., Jones, A., Vogtsberger, K. N., & Estrada, A. L. (1991, October). Composite measures of "safe" and "risky" needle use. Presented at the Third Annual Meeting of the National AIDS Demonstration Research (NADR) Project, Washington, DC.
Open response
1.b In the last 6 months before entering this treatment, how often did you inject drugs with a needle?
2.b How often did you use needles or syringes that were “dirty” -- that is, that someone else had used and were not sterilized or cleaned with bleach before you used them?
3.b And how often did you use the same cooker, cotton, or rinse water that someone else had already used?
4. Altogether, how many PEOPLE did you share the same works with during those 6 months? This means all the people who used the same needles or syringes, cooker, cotton, or rinse water before you did?
5. In the last 30 days before this treatment, how many TIMES did you inject drugs with a needle?
6. How many times did you use needles or syringes that were “dirty” -- that is, that someone else had used and were not sterilized or cleaned with bleach before you used them?
7. How many of the times you injected in those 30 days did you use the same cooker, cotton, or rinse water that someone else had already used?
8. And how many of the times that you injected drugs were you with other people who were also injecting?
9. Altogether, how many PEOPLE did you share the same works with in those 30 days? This means all the people who used the same needles or syringes, cooker, cotton, or rinse water before you did.
10. What about SEX in the last 6 months before entering this treatment? How many
PEOPLE did you have sex with during that time (including vaginal, oral, or anal)?
11. During those months, how often did you have sex WITHOUT USING A LATEX CONDOM while
a. with someone who was not your spouse or primary partner?.............0 1 2 3 4
b. with someone who shoots drugs with needles?................................. 0 1 2 3 4
c. trading, giving, or getting sex for drugs, money, or gifts?................... 0 1 2 3 4
0 = never
1 = only few times
2 = 1-3 times month
3 = 1-5 week
4 = about everyday
12. And what about SEX in the last 30 days before entering this treatment? How many
PEOPLE did you have any kind of sex with during that month (including vaginal, oral, or anal)?
13. How many of your partners were female and how many were male?
14. Altogether, how many times did you have sex that month?
15. And how many times did you have sex without using a latex condom?
16. When you had sex without using a latex condom that month, how many times was it
a. with someone who is not your spouse or primary partner?..........|___|___|___|
b. with someone who shoots drugs with needles?............................|___|___|___|
c. with someone who sometimes smokes crack/cocaine?................|___|___|___|
d. while you or your partner were “high” on drugs or alcohol?.......|___|___|___|
e. while trading (giving/getting) sex for drugs, money, or gifts?.....|___|___|___|
f. involving vaginal sex (penis to vagina)?......................................|___|___|___|
g. involving oral sex (mouth to penis/vagina)?................................|___|___|___|
h. involving anal sex (penis to anus)? .............................................|___|___|___|
17. How many PEOPLE have you known personally who have been infected with the AIDS virus (including those who now have AIDS or have died of AIDS)?
18. How many times have you been tested for the AIDS virus (HIV antibody test)?
a. Have you ever tested positive?............................ 0=No 1=Yes 2=Don't know
Finally, I want to ask about your attitudes and concerns about AIDS and the ways you can become infected.
19.e Tell me how much do you agree or disagree with each of these statements.
a. You believe that you could become exposed to the AIDS virus ................ 0 1 2 3 4
b. You think that you really could get AIDS. ..................................................................... 0 1 2 3 4
c. You want to make some changes now that will reduce your AIDS risks 0 1 2 3 4
d. You need help in dealing with your drug use. ......................................................... 0 1 2 3 4
e. You need help to change some of your sex activities. ...................................... 0 1 2 3 4
f. You get tired of the problems caused by drugs. ...................................................... 0 1 2 3 4
g. You are going to change your drug use activities to avoid AIDS. .............. 0 1 2 3 4
h. You are going to change your sex activities to avoid AIDS. ........................... 0 1 2 3 4
i. You already know what you must do to reduce your AIDS risks. ................ 0 1 2 3 4
j. You feel sure of yourself in controlling your risky drug use activities ....... 0 1 2 3 4
k. You feel sure of yourself in controlling your risky sex activities ................... 0 1 2 3 4
Cronbach's alpha =0.7
Predictive validity
View article on Google Scholar
Individuals may use this information for research or educational purposes only and may not use this information for commercial purposes. When using this instrument, please cite:
1. Joe, G. W., Menon, R., Copher, J. I., & Simpson, D. D. (1990, December). Needle-use and sex risk indices: A methodological report. Research in Progress: National AIDS Demonstration Research (NADR) Project. Bethesda, MD: NOVA Research Company. 2. Joe, G. W., Simpson, D. D., Watson, D. D., Williams, M. L., Jones, A., Vogtsberger, K. N., & Estrada, A. L. (1991, October). Composite measures of "safe" and "risky" needle use. Presented at the Third Annual Meeting of the National AIDS Demonstration Research (NADR) Project, Washington, DC.
When presenting results using any survey information you obtained from the SABI, please acknowledge the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410.